General Information


DRAVP ID  DRAVPe00162

Peptide Name   P6-2

Sequence  LCDCPNGPWVWVPAFCQAVG

Sequence Length  20

UniProt ID  No entry found

Source  Synthetic construct(derived from region of GB virus C glycoprotein E2)



Activity Information


Target Organism  HIV

Assay  Luciferase assay

Activity 

  • [Ref.21543477]HIV-1(NL4-3):inhibition of HIV replication(IC50=2.3 μM);
  • HIV-1(YU-2):inhibition of HIV replication(IC50=2.4 μM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  membrane

Mechanism  The possible mechanism of action is that the peptide could inhibit membrane fusion and inhibit HIV-1 replication in cells.



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Acetylation

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C99H140N24O25S3

Absent amino acids  EHIKMRSTY

Common amino acids  CPV

Mass  2162.53

Pl  3.8

Basic residues  0

Acidic residues  1

Hydrophobic residues  9

Net charge  -1

Boman Index  1312

Hydrophobicity  62

Aliphatic Index  73

Half Life 

  •     Mammalian:5.5 hour
  •     Yeast:3 min
  •     E.coli:2 min

Extinction Coefficient cystines  11125

Absorbance 280nm  585.53

Polar residues  6



Literature Information


Literature 1

Title   Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.

Pubmed ID   21543477

Reference   J Virol. 2011 Jul;85(14):7037-47.

Author   Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. 

DOI   10.1128/JVI.02366-10